High Biocompatible ZIF-8 Coated by ZrO2 for Chemo-microwave Thermal Tumor Synergistic Therapy.

Liuhui Su,Qiong Wu,Longfei Tan,Zhongbing Huang,Changhui Fu,Xiangling Ren,Na Xia,Zengzhen Chen,Xiaoyan Ma,Xudong Lan,Qiang Zhang,Xianwei Meng
DOI: https://doi.org/10.1021/acsami.8b22177
IF: 9.5
2019-01-01
ACS Applied Materials & Interfaces
Abstract:Zeolitic imidazolate framework (ZIF-8) is specifically promising for drug carrier due to its excellent intrinsic properties. However, the high toxicity of ZIF-8 nanoparticles severely limits its further research and clinical application. In the work, the biocompatibility of ZIF-8 nanoparticles are greatly improved by coating ZrO2 onto the surface. The survival rate of cells and mice in the ZIF-8@ZrO2 nanocomposites group is significantly increased compared with the undecorated ZIF-8 nanoparticles group. Doxorubicin (DOX) as a chemotherapeutic drug is deposited during the ZIF-8 growth by a facile one-pot method. Ionic liquid (IL) is loaded into the pore of the ZIF-8/DOX@ZrO2 nanocomposites for enhanced microwave thermal therapy. The tumor inhibition rate of ZIF-8/DOX@ZrO2@IL nanocomposites with synergistic microwave thermal therapy and chemotherapy is obviously higher than other groups. In addition, the ZIF-8/DOX@ZrO2@IL nanocomposites are used for real-time monitoring of the therapeutic outcomes due to the excellent CT contrast agent of ZrO2. Therefore, such ZrO2 coating strategy shows great promise for overcoming high toxicity of ZIF-8 nanoparticles, which offers a new platform for tumor synergistic microwave thermal therapy and chemotherapy using ZIF-8/DOX@ZrO2@IL nanocomposite as a theranostic nanocarrier.
What problem does this paper attempt to address?